No profile data available.
ANG Lifesciences India Limited (ANG.BO) is a healthcare company in the drug manufacturing contractors industry, based in Amritsar, India, with about 379 full-time employees.
It reported revenue of 927.90 million INR for fiscal year 2026, up 0.3% from fiscal year 2025, and net income of -110.85 million INR. In Q1 2027 (the quarter ended June 30, 2026) revenue was 152.98 million INR, down 37.8% from a year before. Its market capitalization was 474.54 million INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor.
ANG Lifesciences India reported 927.90 million INR in revenue for fiscal year 2026, up 0.3% from 925.41 million INR in fiscal year 2025. In Q1 2027 revenue was 152.98 million INR.
474.54 million INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Tyche Industries Limited (TYCHE.BO), Sunil Healthcare Limited (SUNLOC.BO), Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS), Mangalam Drugs & Organics Limited (MANGALAM.NS).